1,957
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Baicalein blocked cervical carcinoma cell proliferation by targeting CCND1 via Wnt/β-catenin signaling pathway

, , , , , , & show all
Pages 2729-2736 | Received 29 Apr 2019, Accepted 25 May 2019, Published online: 08 Jul 2019

References

  • Di Domenico F, Foppoli C, Coccia R, et al. Antioxidants in cervical cancer: chemopreventive and chemotherapeutic effects of polyphenols. Biochim Biophys Acta. 2012;1822:737–747.
  • Peng Y, Guo C, Yang Y, et al. Baicalein induces apoptosis of human cervical cancer HeLa cells in vitro. Mol Med Rep. 2015;11:2129–2134.
  • Mandal SK, Biswas R, Bhattacharyya SS, et al. Lycopodine from Lycopodium clavatum extract inhibits proliferation of HeLa cells through induction of apoptosis via caspase-3 activation. Eur J Pharmacol. 2010;626:115–122.
  • Park SE, Yoo HS, Jin CY, et al. Induction of apoptosis and inhibition of telomerase activity in human lung carcinoma cells by the water extract of Cordyceps militaris. Food Chem Toxicol. 2009;47:1667–1675.
  • Tsang PW, Chau KY, Yang HP. Baicalein exhibits inhibitory effect on the energy-dependent efflux pump activity in non-albicans Candida fungi. J Chemother. 2015;27:61–62.
  • Liu H, Dong Y, Gao Y, et al. The fascinating effects of baicalein on cancer: a review. IJMS. 2016;17:1681.
  • Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol. 2002;3:11–20.
  • Lapenna S, Giordano A. Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov. 2009;8:547–566.
  • Li N, Zeng J, Sun F, et al. p27 inhibits CDK6/CCND1 complex formation resulting in cell cycle arrest and inhibition of cell proliferation. Cell Cycle. 2018;17:2335–2348.
  • Yang L, Ye F, Bao L, et al. Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancers. Cancer Sci. 2019;110:1389–1400.
  • Chan AW, Zhang Z, Chong CC, et al. Genomic landscape of lymphoepithelioma-like hepatocellular carcinoma. J Pathol. 2019. [Epub ahead of print]. doi: 10.1002/path.5313
  • Karim S, Al-Maghrabi JA, Farsi HM, et al. Cyclin D1 as a therapeutic target of renal cell carcinoma – a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia. BMC Cancer. 2016;16:741.
  • Wu B, Crampton SP, Hughes CC. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity. 2007;26:227–239.
  • Murad LB, da Silva Nogueira P, de Araujo WM, et al. Docosahexaenoic acid promotes cell cycle arrest and decreases proliferation through WNT/β-catenin modulation in colorectal cancer cells exposed to γ-radiation. Biofactors. 2019;45:24–34.
  • Planutiene M, Planutis K, Holcombe RF. Lymphoid enhancer-binding factor 1, a representative of vertebrate-specific Lef1/Tcf1 sub-family, is a Wnt-beta-catenin pathway target gene in human endothelial cells which regulates matrix metalloproteinase-2 expression and promotes endothelial cell invasion. Vasc Cell. 2011;3:28.
  • Mao D, Qiao L, Lu H, et al. B-cell translocation gene 3 overexpression inhibits proliferation and invasion of colorectal cancer SW480 cells via Wnt/β-catenin signaling pathway. Neoplasma. 2016;63:705–716.
  • Gore AJ, Deitz SL, Palam LR, et al. Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation. J Clin Invest. 2014;124:338–352.
  • Lee TI, Johnstone SE, Young RA. Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat Protoc. 2006;1:729–748.
  • Lyakhovich A, Surralles J. Constitutive activation of caspase-3 and Poly ADP ribose polymerase cleavage in fanconi anemia cells. Mol Cancer Res. 2010;8:46–56.
  • Wachtel M, Schafer BW. Targets for cancer therapy in childhood sarcomas. Cancer Treat Rev. 2010;36:318–327.
  • Caldon CE, Sutherland RL, Musgrove E. Cell cycle proteins in epithelial cell differentiation: implications for breast cancer. Cell Cycle. 2010;9:1918–1928.
  • Broceno C, Wilkie S, Mittnacht S. RB activation defect in tumor cell lines. Proc Natl Acad Sci USA. 2002;99:14200–14205.
  • Dellinger TH, Planutis K, Tewari KS, et al. Role of canonical Wnt signaling in endometrial carcinogenesis. Exp Rev Anticancer Ther. 2012;12:51–62.
  • Gurney A, Axelrod F, Bond CJ, et al. Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc Natl Acad Sci USA. 2012;109:11717–11722.
  • Chan DW, Mak CS, Leung TH, et al. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer. Oncotarget. 2012;3:1546–1556.
  • Machin P, Catasus L, Pons C, et al. CTNNB1 mutations and beta-catenin expression in endometrial carcinomas. Hum Pathol. 2002;33:206–212.
  • Sukhdeo K, Mani M, Zhang Y, et al. Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma. Proc Natl Acad Sci USA. 2007;104:7516–7521.
  • Rasmussen ML, Ortolano NA, Romero-Morales AI, et al. Wnt signaling and its impact on mitochondrial and cell cycle dynamics in pluripotent stem cells. Genes (Basel). 2018;9:109.
  • Vadlakonda L, Pasupuleti M, Pallu R. Role of PI3K-AKT-mTOR and Wnt signaling pathways in transition of G1-S phase of cell cycle in cancer cells. Front Oncol. 2013;3:85.
  • Matsu-Ura T, Moore SR, Hong CI. WNT takes two to tango: molecular links between the circadian clock and the cell cycle in adult stem cells. J Biol Rhythms. 2018;33:5–14.
  • Zhu JT, Choi RC, Chu GK, et al. Flavonoids possess neuroprotective effects on cultured pheochromocytoma PC12 cells: a comparison of different flavonoids in activating estrogenic effect and in preventing beta-amyloid-induced cell death. J Agric Food Chem. 2007;55:2438–2445.
  • Wang CZ, Li XL, Wang QF, et al. Selective fraction of Scutellaria baicalensis and its chemopreventive effects on MCF-7 human breast cancer cells. Phytomedicine. 2010;17:63–68.
  • Shang D, Li Z, Zhu Z, et al. Baicalein suppresses 17-beta-estradiol-induced migration, adhesion and invasion of breast cancer cells via the G protein-coupled receptor 30 signaling pathway. Oncol Rep. 2015;33:2077–2085.